Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Year 3 > Transplantation > Flashcards

Transplantation Flashcards

1
Q

name the types of graft

A

xenograft
allografy
isograft
autograft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a xenograft?

A

tissue graft or organ transplant from a donor of a different species from the recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is an allograft?

A

the transplant of an organ or tissue from one individual to another of the same species with a different genotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is an isograft?

A

from a donor who is genetically identical to the recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

do isograft receivers still need immunouppression and why?

A

yes because they will have been exposed to different things e.g. blood transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is an autograft?

A

a graft of tissue from one point to another of the same individual’s body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is MHC?

A

The major histocompatibility complex (MHC) is a set of cell surface proteins essential for the acquired immune system to recognize foreign molecules in vertebrates, which in turn determines histocompatibility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is histocompatibility?

A

Histocompatibility, or tissue compatibility, is the property of having
the same, or sufficiently similar, alleles of a set of genes called human leukocyte antigens (HLA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the inheritance of HLS

A

codominantly

two alleles 6 loci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name the major requirements for tissue typing?

A

HLA-DR, DP, DQ
HLA-A, B, C
ABO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe class 1 HLA

A

The class I molecules are responsible for presenting antigenic peptides from within the cell (eg, antigens from the intracellular viruses, tumour antigens, self antigens) to CD8 T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

descibe class 2 HLA

A

the class II molecules present extracellular antigens such as bacteria to CD4 T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

where are HLA class I found?

A

all nucleated cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what recognised HLA I

A

CD8+

Tc cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

where are HLA class II found?

A

APCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what recognised HLA II?

A

CD4+

Th cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what kind of HLA is most important in rejection?

A

class II

18
Q

draw a molecule of HLA1 and 2

A

see notes

19
Q

The MHC genes are codominantly expressed, which means that each individual expresses these genes from both the alleles on the cell surface. what does this mean in regards to transplant?

A

they are inherited as haplotypes or 2 half sets (one from each parent).t This makes a person half identical to each of his or her parents with respect to the MHC complex. This also leads to a 25% chance that an individual might have a sibling who is HLA identical. Only 30% of transplant recipients have an HLA identical donor.

20
Q

what are privileged sites?

A

no vascularisation so:
no sensitisation/no tolerance
no requirement for tissue matching
no immunosuppression

21
Q

give examples of transplants wth privileged sites

A

corneal

heart valves

22
Q

types of living donor

A

related or unrelated

altruistic

23
Q

types of deceased donor

A

brain death

cadaveric death

24
Q

with living donors there is:

A 
less rejection
quicker
last longer
healthier
easier to manage
25
Q

what is graft rejection?

A

Transplant rejection occurs when transplanted tissue is rejected by the recipients immune system, which destroys the transplanted tissue.

26
Q

causes of graft rejection

A 
• ABO or HLA incompatible
• Pre-formed immunity – sensitisation
• Failed immunosuppression
o Including non-compliance
• Infections/environmental triggers
o CMV esp
27
Q

describe hyperacute rejection

A

This can happen in seconds as a result of ABO/HLA antibodies. It causes complement activation damaging blood vessels. Inflammation and thrombosis results.

28
Q

risk factors for hyperacute rejection

A

previous failed transplants
pregnancies
blood transfusions

29
Q

what kind of transplants are esp at risk of hyperacute rejection?

A

kidney

30
Q

describe the sensitisation phase in acute rejection

A
  • CD4 and CD8 cells recognise alloantigens
  • T-cell receptors react with APCs via MHC molecules
  • Co-stimulation via CD28, CD80 and CD4/40 surface ligands
31
Q

describe acute rejection

A

Occurs in days to months up to 6 months Acute rejection usually occurs in the 1st 6 months of transplantation. It can be a mix of cell and antibody mediated rejection. Cellular infiltration of graft by TC cells, B-cells, NK cells and macrophages. Endothelial inflammation and parenchymal cell damage. Host T cells recognise intact allo-MHS molecules on the surface of tissues. Unlike T and B cells, NK cells are activated by the absence of MHC molecules on the surface of target cells (“missing self” hypothesis). The recognition is mediated by various NK inhibitory receptors triggered by specific alleles of MHC class I antigens on cell surfaces. Often develops into chronic.

32
Q

describe chronic rejection

A

Chronic rejection is the commonest cause of graft failure occurring after 6 months. It is antibody mediated with other innate components. There is myointimal proliferation in arteries. Cytokines and antibodies cause a chronic inflammatory process that proliferates cell walls to protect themselves and due to turnover. This in turn blocks off blood vessels and leads to ischaemia and fibrosis

33
Q

what is the treatment of rejection?

A

• Corticosteroids
• Anti-thymocyte globulin
o Must find out about horse or rabbit allergies
• Plasma exchange
o Antibody mediated rejection
o IV Ig added so that they don’t get common infections

34
Q

apart from rejection, list the other complications of transplantation

A
  • Infection (including zoonotic)
  • Neoplasia (skin, lymphoma)
  • Drug side effects
  • Recurrence of original disease
  • Surgical, ethical problems
35
Q

how can you prevent transplant rejection?

A
  • ABO matching
  • Tissue typing (Class I and II HLA)
  • Prophylactic immunosuppression
  • (humanised or silenced xenografts)
36
Q

list the types of immunosuppressants and what they do

A 
• Corticosteroids (Prednisolone)
o Widespread anti-inflammatory
• Calcineurin Inhibitors (Tacrolimus)
o Block IL-2 Gene Transcription
• Anti-proliferatives (MMF)
o Prevent Lymphocyte Proliferation
37
Q

graft vs host disease is primarily found in what kind of transplant?

A

bone marrow

38
Q

requirements of graft vs host disease

A

o Immunocompetent cells in graft
o Defective recipient immunity
Figure 7 Complications of Renal Transplantation
o HLA differences between donor and recipient

39
Q

prevention of graft vs host disease

A

o Donor / recipient matching

o Donor marrow T cell depletion

40
Q

what does unmodified xenografts result in?

A

hyperacute rejection

41
Q

natural IgM human anti-swune antibody result sin what in unmodified xenografts?

A

graft endothelial galactose residuses

42
Q

prevention of xenograft hyperacute rejection

A

1) Remove antibody from recipient
2) Genetically modified (‘silenced’) pigs
3) ‘Humanised’ transgenic pigs

Year 3 (164 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions